Century Therapeutics (IPSC) PT Lowered to $17 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts IPSC Hot Sheet
Price: $2.03 -8.97%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
H.C. Wainwright analyst Mitchell Kapoor lowered the price target on Century Therapeutics (NASDAQ: IPSC) to $17.00 (from $19.00) while maintaining a Buy rating.
You May Also Be Interested In
- Baird Upgrades Titan Machinery (TITN) to Outperform
- RoboSense Technology (2498:HK) PT Lowered to NT$30.60 at Macquarie
- Marvell (MRVL) PT Raised to $325 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
